| |
| |
7:00 – 8:30
Registration & Networking |
| |
|
| |
| |
| |
9:15 – 10:15
API Sourcing: How Well Are Suppliers Responding To The Constant Change?
Roger P. Bakale, Ph.D.
Senior Director, Worldwide Chemical Process R&D
Cephalon, Inc. |
Tricia Scialla
Director, Chemical Development
Wyeth Research |
Laurie Chipperfield
Director API Strategic Sourcing & Planning
Pfizer
|
Ian Cottrell, Ph.D.
Director, External Services
Merck |
|
|
|
| |
10:15 – 11:15
Networking
and Refreshments |
| |
11:15 – 12:15
Supply Chain to Chemical Sourcing in Asia: What Are Supplier Plans To Ensure Availability of Raw Materials?
Rick Connell, Ph.D.
Worldwide Head of Chemistry Sourcing
VP of Research Outsourcing |
John Ellingboe, Ph.D.
Assistant Vice President, Exploratory Chemistry
Wyeth Research |
John McGill, Ph.D.
Director, External Discovery Research
Eli Lilly & Company
|
Thomas Sowin, Ph.D.
Senior Project Leader,
Global Discovery Chemistry
Abbott Laboratories |
David M. Stout, Ph.D.
Director
Merck & Co., Inc. |
|
|
| |
12:15 – 1:30
Networking Luncheon |
| |
| |
|
|
|
1:30 – 2:30
Sourcing Synthetic Route Design and Process Optimization
Conrad Hummel, Ph.D.
Associate Director, Business Operations
Array BioPharma
Jan Oudenes, Ph.D.
President & CEO
Alphora Research
John E. Schurig, Ph.D.
Vice President, Preclinical Development
BTG International
Michael Semo
Outsourcing Consultant
Eli Lilly and Company
Lijun Sun, Ph.D.
VP, Chemistry
Synta Pharmaceuticals Corp.
Andrew Thompson
President
J-Star Research
Ken Wells, Ph.D.
Principal Scientist, High Output Synthesis, Drug Discovery
Johnson & Johnson PRD
|
1:30 – 2:30
Balancing Your Outsourcing Portfolio: What Goes Overseas & What Stays Home?
Peter G. Houghton, Ph.D.
Chemical Product R&D
Eli Lilly and Company
Jeff W. Jacobs, Ph.D.
Vice President, Medicinal Chemistry
Nteryx, Inc
Ving Lee, Ph.D.
CEO/CSO
Adesis
Thomas J. Niemeyer
API Strategic Sourcing and Planning
Pfizer Global Research and Development
Philip Roberts
Senior Director, Manufacturing & Outsourcing
Exelexis
Mark W. Sawicki, Ph.D.
Director, Business Development
Albany Molecular Research
Scott Zook
Director of Chemical Development
Neurocrine Biosciences
|
1:30 – 2:30
Why Not Look For New Molecules Abroad? External Science Collaborations
Ming Guo, Ph.D.
VP, Pharmaceutical Sciences & Manufacturing
General Manager,
Ascenta (Shanghai) R&D Center
Ascenta Therapeutics, Inc.
J B Gupta, Ph.D.
Head of Collaborative Research
GVK Biosciences Pvt. Ltd.
Steven Tushup
Contract Synthesis Manager
Merck & Co., Inc.
Dean Wilson, Ph.D.
Associate Director, Chemistry
Vertex Pharmaceuticals
Christopher Yochim
Associate Director, External Relations
AstraZeneca Pharmaceuticals |
1:30 – 2:00
Supplier Performance Metrics
Dean Wilson, Ph.D.
Associate Director, Chemistry
Vertex Pharmaceuticals
2:00 – 2:30
Chemistry Services Outsourcing - Early Phase Drug Discovery
Duncan Judd, Ph.D.
Outsourcing Manager, Discovery Medicinal Chemistry
GlaxoSmithKline
|
|
| |
2:30 – 3:30
Networking and Exhibits |
| |
3:30 – 4:30
Sourcing Key Starting Materials: Excipients, Rare Reagents & Other Non-Commodity Ingredients
Kathleen Gabrielski CPM
Global Strategic Sourcing
Schering Corporation
Aída Pérez-Martí
Global Procurement -Direct Materials and Capital Procurement
Merck & Company
Jeffrey L. McGehee
Senior Manager, Strategic Sourcing & Procurement
Intervet/Schering-Plough Animal Health
Nalukui Mwisiya
Senior Scientific Sourcing Specialist
Wyeth Research
Stuart Silverman
Pharmaceutical Business Development
Capsugel, a division of Pfizer
4:30 – 5:30
Import & Export Logistics, Risk Management, Transportation & Documentation
Charles Calvert
Senior Director, Procurement
Pfizer Global Research & Development
Zhengming (Jimmy) Chen, Ph.D.
Vice President, Chemistry and PRD
DOV Pharmaceutical, Inc.
John Hollenbach
Director of Sales & Marketing
Doe & Ingalls of North Carolina
Tomas Kaplan
Senior Outsourcing Specialist
Array BioPharma
Udo Quotschalla, Ph.D.
Senior Director, Head of Global NCE Process R&D
UCB Group
|
3:30 – 4:30
Technical Packages for Contract Manufacturing: Quotes, Contracts, and Final Reports
Sandra Moro
Senior Manager, Business Development USA
Helsinn Chemicals SA
Conrad Hummel, Ph.D.
Associate Director, Business Operations
Array BioPharma
Rob Maddox
President
PharmaCore
Wanda Tormos
Senior Manager, Chemical Development
Gilead Sciences
James Tornos Ph.D.
Associate Director, Procurement & Outsourcing
Pfizer
Winston Wu, Ph.D.
Director, Process Chemistry
Lexicon Pharmaceuticals
Shuguang Zhu, Ph.D.
Director, Process Chemistry
Ardea Biosciences
4:30 – 5:30
Models for Drug Discovery Collaboration: FTE, BOT and Risk-Reward Sharing
Swapan Bhattacharya
Managing Director
TCG Lifesciences
M. Bhupathy, Ph.D.
Executive Director, Chemistry R & D Outsourcing
Amgen
Goutam Das, Ph.D.
Chief Operating Officer
Syngene International
John Ellingboe, Ph.D.
Assistant Vice President, Exploratory Chemistry
Wyeth Research
Narendra Mallakunta
Global Head of Business Development
GVK Biosciences Inc.
John McGill, Ph.D.
Director, External Discovery Research
Eli Lilly & Company
Sri Mosur
CEO & President
Jubilant Biosys Ltd. |
3:30 – 4:30
Sourcing in Phase II to Facilitate the Commercial Activity
Kelly K. Catlin, Ph.D.
API Strategic Sourcing and Planning
Pfizer Global Research and Development
Alan Harris
Associate Director Of Business Development, Global Process R & D
AstraZeneca
David J. Houser
AD of Business Development
Asymchem Laboratories
Cuong Lu
API Strategic Sourcing & Planning, Global Supply Chain
Pfizer
Premchandran Ramiya, Ph.D.
Director, Process Development & Manufacturing
Geron Corporation
Shabbir Rangwala
VP, Clinical Research
GVK Biosciences Pvt. Ltd.
4:30 - 5:30
Biotechs Special Case: The Need for Speed
Philip Bauer, Ph.D.
Director, Process Chemistry and CMC
Gemin X Pharmaceuticals
Hui-Yin Harry Li, Ph.D.
President
Wilmington PharmaTech
Stuart Needleman
Vice President, Sales and Marketing
Aptuit
Maxwell M. Reeve, Ph.D.
Associate Director, Chemistry Manufacturing Management
Rib-X Pharmaceuticals
Silvina Garcia Rubio, Ph.D.
Director, CMC Development
Sapphire Therapeutics, Inc.
Keith Drouet, Ph.D.
Senior Director of Business Development
Cambridge Major Laboratories
Gary Visor, Ph.D.
Vice President, Chemical Operations and Pharmaceutics
Plexxikon
Roger Xie, Ph.D.
Associate Director, Chemical Operations
Sirtris Pharmaceuticals |
3:30 – 4:00
M & A in Fine & Specialty Chemicals
Chris Cerimele
Managing Director & Co-Head, Global Chemicals
Lincoln International
4:00 – 4:30
Making It All Work: A Global Drug Discovery Alliance with 5 Partners
Allan R. Moorman, Ph.D.
Senior Director, Medicinal Chemistry
King Pharmaceuticals
4:30 – 5:00
Utilizing CROs in Asia to Create an Integrated Outsourcing Platform
Roger Xie, Ph.D.
Associate Director, Chemical Operations
Sirtris Pharmaceuticals
5:00 – 5:30
EU Chemical Registration & REACH Readiness
Darlene Hall
Principal Scientist, API Strategic Sourcing
Pfizer
|
| |
|
|
|
5:30 – 6:30
Exhibitor Presentations in Ballrooms A, B & C |
| |
6:30 – 9:30
Reception & Casino Night Gaming |
| |
| |
 |
 |
Tuesday, September 9, 2008 - DAY 2 |
| |
7:15 – 8:30
Networking and Exhibits |
| |
| |
|
|
|
|
8:30 – 9:30
How Will Recent Events in China Effect the Cost of Sourcing?
Robert Antonucci
Director of Supply Chain
Javelin Pharmaceuticals
Laurie Chipperfield
Director API Strategic Sourcing & Planning
Pfizer Global R&D
Hui-Yin Harry Li, Ph. D.
President
Wilmington PharmaTech
Tricia Scialla
Director, Material Operations
Chemical Development
Winston Wu, Ph.D.
Director, Process Chemistry
Lexicon Pharmaceuticals
Roger Xie, Ph.D.
Associate Director, Chemical Operations
Sirtris Pharmaceuticals
|
8:30 – 9:30
Chiral Synthesis: Early Project Application to Solve a Common Problem
Richard Boehner
President
Symyx Research
Donald Mammato, Ph.D.
Vice President Business Development
Novasep Synthesis
Prashant S. Savle, Ph.D.
Manager, Sourcing
Schering Plough Research Institute
William H. Tamblyn, Ph.D.
Director, Commercial Development
Johnson Matthey Catalysts
Ton Vries
CEO
Syncom BV
Gary Willingham, Ph.D.
Business Development Director
Solvias, Inc.
|
8:30 – 9:30
Int'l Project Team Communication: Culture, Language, Distance, Personalities
Curtis Cui
Associate Director - API Manufacturing
Inspire Pharmaceuticals
Q. Kevin Fang, Ph.D.
Director, Medicinal Chemistry
Sepracor Inc.
Peter G. Houghton, Ph.D.
Research Advisor, Chemical Product R&D
Lilly Research Laboratories
Arvind Mathur, Ph.D.
Associate Director, Discovery Chemistry
Bristol-Myers Squibb
Scott A. Miller, Ph.D.
Senior Director, Process Chemistry
Adolor Corporation
Richard Soll, Ph.D.
Vice President of Medicinal Chemistry
WuXi PharmaTech
Peter van Tilburg
General Director / President
CML Europe BV
|
8:30 – 9:00
Managing Discovery Chemistry Outsourcing Build A Partnership
Lijun Sun, Ph.D.
VP, Chemistry
Synta Pharmaceuticals
9:00 – 9:30
From Medicinal Chemistry to API Manufacturing, A Small Biopharma's Outsourcing Road Map
Zhengming (Jimmy) Chen, Ph.D.
Vice President, Chemistry and PRD
DOV Pharmaceutical, Inc.
|
| |
9:30 – 10:30
Networking and Exhibits |
| |
| |
|
|
|
|
10:30 – 11:30
New Process Intensification Technologies: Scaling up Hazardous Chemistries and Reducing Impurities
Sean Bradley
Director of Business Development
Regis Technologies
Mike Cruskie, Ph.D.
Vice President, Business Development
IRIX Pharmaceuticals
Deborah Minor, Ph.D.
President
Drug Discovery Alliances
Pasit Phiasivongsa, Ph.D.
Senior Manager, Chemical Development
Proteolix, Inc.
Inder Pal Singh, Ph.D.
Director Business Development
SBI Fine Chemicals, Inc
Prashant S. Savle, Ph.D.
Manager, Sourcing, Chemical & Physical Sciences
Schering-Plough Research Institute
|
10:30 – 11:30
Finding Good Medicinal Chemistry Partners
Christelle Renou
Outsourcing Manager
Millennium Pharmaceuticals
Normand Hebert, Ph.D.
Director, Lead and Contract Chemistry
SGX Pharmaceuticals
Mark Warne, Ph.D.
Managing Director
Exelgen, Ltd
Ashis Saha, Ph.D.
Vice President of Research
Chembiotek
Mark W. Sawicki, Ph.D.
Director, Business Development
Albany Molecular Research
C. Eric Schwartz, Ph.D.
Senior Director, Medicinal Chemistry
Resolvyx Pharmaceuticals
Dan Warner
Manager, Strategic External Resourcing
Novartis Institutes for BioMedical Research
David Zimmermann
Chief Executive Officer
Kalexsyn
|
10:30 – 11:30
How Much Regulatory Is Right For My Project? Also, REACH & SEMA Impact
Philip Bauer, Ph.D.
Director, Process Chemistry and CMC
Gemin X Pharmaceuticals
Darlene Hall
Principal Scientist, API Strategic Sourcing
Pfizer
Steve Kent
Business Development Manager
AstraZeneca Brixham Environmental Laboratory
Harry Kochat, Ph.D.
VP, Process Development and Manufacturing
Bionumerik Pharmaceuticals
Mike Scannell, Ph.D.
Director, Process Chemistry
SCYNEXIS
Glenn Noronha, Ph.D.
Director, Chemistry
TargeGen, Inc
Stuart Silverman
Pharmaceutical Business Development
Capsugel, a division of Pfizer
Mike Williams, Ph.D.
Director, Pharmaceutical Research & Development
Targacept, Inc.
|
10:30 – 11:00
The Need for More Effective Supplier Regulatory Oversight in Asia
Charles Calvert
Senior Director, Procurement
Pfizer Global Research & Development
11:00 – 11:30
Lilly's Approach to Outsourcing Process Development
Michael Semo
Outsourcing Consultant, Chemical Product R&D Outsourcing
Eli Lilly and Company
11:30 – 12:00
Advancing Agent Business Models
Carol Rose
Team Leader/Sourcing Lead
Pfizer
|
| |
12:00 – 1:15
Networking Luncheon |
| |
| |
|
|
|
1:15 – 2:15
Technology Transfer: PRD & IP
Edward Cheesman, Ph.D.
Director, API Development
Lantheus Medical Imaging
John Donaubauer, Ph.D.
Senior Project Leader
Abbott Laboratories
Alan Harris
Associate Director Of Business Development, Global Process R & D
AstraZeneca
Cuong Lu
API Strategic Sourcing & Planning, Global Supply Chain
Pfizer
Gale F. Matthews, Esq.
Assistant General Counsel-Patents
Wyeth
Maxwell M. Reeve, Ph.D.
Associate Director, Chemistry Manufacturing Management
Rib-X Pharmaceuticals
Thomas M. Saunders
Partner
Seyfarth Shaw LLP
2:15 – 3:30
Supplier Performance Metrics: Gauging Value on Your Relationships
Manni Kantipudi
President
GVK Biosciences Pvt. Ltd.
Stuart Needleman
Vice President, Sales and Marketing
Aptuit
Glenn Noronha, Ph.D.
Director, Chemistry
TargeGen
Mark Ralph
Manager, Medicinal Chemistry
Boehringer Ingelheim
Debra Sponholtz, Ph.D.
Director, Business Development
Chembiotek
Wanda Tormos
Senior Manager, Chemical Development
Gilead Sciences
Steven Tushup
Contract Synthesis Manager
Merck & Co
|
1:15 – 2:15
Selecting Commercial Suppliers: Sites Visits, Agents, Facilities, Culture, Response PAT Initiative
Jim Hamby, Ph.D.
Director of Business Development
Ash Stevens
Premchandran Ramiya, Ph.D.
Director, Process Development & Manufacturing
Geron Corporation
Carol Rose
Team Leader/Sourcing Lead API Strategic Sourcing and Planning
Pfizer
2:15 – 3:30
Manufacturing Hazardous, Difficult, and Potent APIs
Nick Bockovich, Ph.D.
Director of Pharmaceutical Development
GPC Biotech
David J. Houser
AD of Business Development
Asymchem Laboratories
Arun Kaura, Ph.D.
Investigator, Medicinal Chemistry/Oncology
GlaxoSmithKline
Scott A. Miller, Ph.D.
Senior Director, Process Chemistry
Pharmaceutical Technologies
Adolor Corporation
Thierry Van Nieuwenhove
Business Unit Manager, Pharmaceutical Fine Chemicals
Ajinomoto OmniChem N.V
Stuart Silverman
Pharmaceutical Business Development
Capsugel, a division of Pfizer
Sue Wollowitz, Ph.D.
VP, Chemistry and Manufacturing
Medivation, Inc.
|
1:15 – 2:15
Sourcing Finished Dose Manufacturing
Gerald Burke, Ph.D.
Director, Clinical and Commercial Manufacturing
Javelin Pharmaceuticals
Udo Quotschalla, Ph.D.
Senior Director, Head of Global NCE Process R&D
UCB
Agnes Shanley
Editorial Director
Putman Media Pharma Group
Stuart Silverman
Pharmaceutical Business Development
Capsugel, a division of Pfizer
Padraig Somers
General Manager
Helsinn Birex Pharmaceuticals Ltd
2:15 – 3:30
I Have to Scale Up to 20 Kilos in 6 Months How Am I Going to Get This Done?
Scott Chadwick, Ph.D.
Director Chemical & Pharmaceutical Operations
Anthera Pharmaceuticals, Inc.
Curtis Cui
Associate Director - API Manufacturing
Inspire Pharmaceuticals, Inc.
Deborah Minor, Ph.D.
President
Drug Discovery Alliances, Inc.
Gary Visor, Ph.D.
Vice President, Chemical Operations and Pharmaceutics
Plexxikon
Mike Williams, Ph.D.
Director, Pharmaceutical Research & Development
Targacept, Inc.
|
1:15 – 1:45
Procurement of Outsourced Services and Manufacture - What Works Best For You?
James Tornos Ph.D.
Associate Director, Procurement & Outsourcing
Pfizer
1:45 – 2:15
How Does REACH Affect The Pharmaceuticals Industry?
Steve Kent
Business Development Manager
AstraZeneca Brixham Environmental Laboratory
|
| |
3:30
Conference Concludes |
| |
 |
 |
|